Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Category
US Equities - Industry Sector
Sponsor
State Street (SPDR)
Fund Family
Index
S&P Biotechnology Select Industry Index
Index Weighting
Active/Passive
Expense
0.35%
Inverse/Leveraged
IPO
Feb 06, 2006
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-5.12%
SMA50
-5.53%
SMA200
1.34%
Return% 1Y
30.91%
Return% 3Y
30.15%
Return% 5Y
2.38%
Return% 10Y
Return% SI
Flows% 1M
-1.65%
Flows% 3M
-0.79%
Flows% YTD
6.35%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
167
AUM
9.82B
NAV/sh
52W High
169.89 -14.60%
52W Low
113.06 28.32%
Volatility
2.64% 3.17%
ATR (14)
4.95
RSI (14)
40.51
Beta
0.87
Rel Volume
1.05
Avg Volume
9.18M
Volume
4,246,359
Perf Week
-6.44%
Perf Month
-1.88%
Perf Quarter
-14.43%
Perf Half Y
14.43%
Perf YTD
18.99%
Perf Year
26.34%
Perf 3Y
99.67%
Perf 5Y
18.02%
Perf 10Y
118.23%
Prev Close
145.88
Price
145.08
Change %
-0.55%
SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").